Enhancing treatment responses in depression.
D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D001521:Behavior Therapy; D015306:Biogenic Monoamines / Q000502:physiology; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D003213:Conditioning, Psychological / Q000502:physiology; D003243:Consciousness / Q000502:physiology; D003866:Depressive Disorder / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D004644:Emotions / Q000502:physiology; D006801:Humans; D008606:Mental Processes / Q000187:drug effects / Q000502:physiology; D009414:Nerve Growth Factors / Q000502:physiology; D009473:Neuronal Plasticity / Q000502:physiology; D009479:Neuropeptides / Q000502:physiology; D011613:Psychotherapy; D016896:Treatment Outcome
D000928:Antidepressive Agents; D015306:Biogenic Monoamines; D009414:Nerve Growth Factors; D009479:Neuropeptides